Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-4-26
pubmed:abstractText
Amiodarone (AMD) is a strong antiarrhythmic drug but has severe side effects such as pulmonary toxicity. There are no indicators or drugs that can prevent the development of amiodarone-induced pulmonary toxicity (AIPT).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1874-1754
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
30
pubmed:volume
140
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
328-35
pubmed:meshHeading
pubmed-meshheading:19106010-Adolescent, pubmed-meshheading:19106010-Adult, pubmed-meshheading:19106010-Aged, pubmed-meshheading:19106010-Aged, 80 and over, pubmed-meshheading:19106010-Amiodarone, pubmed-meshheading:19106010-Angiotensin II, pubmed-meshheading:19106010-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:19106010-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:19106010-Anti-Arrhythmia Agents, pubmed-meshheading:19106010-Apoptosis, pubmed-meshheading:19106010-Cells, Cultured, pubmed-meshheading:19106010-Dose-Response Relationship, Drug, pubmed-meshheading:19106010-Female, pubmed-meshheading:19106010-Heart Failure, pubmed-meshheading:19106010-Humans, pubmed-meshheading:19106010-Logistic Models, pubmed-meshheading:19106010-Lung Diseases, pubmed-meshheading:19106010-Male, pubmed-meshheading:19106010-Middle Aged, pubmed-meshheading:19106010-Multivariate Analysis, pubmed-meshheading:19106010-Pneumocytes, pubmed-meshheading:19106010-Pulmonary Alveoli, pubmed-meshheading:19106010-Retrospective Studies, pubmed-meshheading:19106010-Risk Factors, pubmed-meshheading:19106010-Survival Analysis
pubmed:year
2010
pubmed:articleTitle
Clinical features of and effects of angiotensin system antagonists on amiodarone-induced pulmonary toxicity.
pubmed:affiliation
Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't